Howard R. Levin, M.D. started his career as an academic cardiologist and researcher and has worked extensively towards the integration of cardiac, respiratory and renal physiological principles into novel clinical treatments.
In 2003, with Mark Gelfand, Dr. Levin co-founded Coridea, an idea generator that translates ideas into novel therapeutic solutions for clinical practice. His inventions and co-inventions have successfully launched or their patents helped launch companies including Ardian (Medtronic), CHF Solutions (Gambro), Respicardia (formerly, Cardiac Concepts), eValve (Abbott) and RenalGuard (PLC Medical), Cibiem and Soffio Medical. He has held a number of positions in these companies including President, Chief Scientific Officer, Chief Medical Officer and VP of R&D. These companies have returned over $1.2 Billon US to their investors.
Prior to joining Coridea, he moved from Johns Hopkins to Columbia Presbyterian where he was a Heart Failure/Transplant Cardiologist and Medical Director of the Mechanical Cardiac Support Program. Dr. Levin received his M.D. from the Mt. Sinai School of Medicine and his training in cardiology at The Johns Hopkins School of Medicine. He also has a master’s degree in Biomedical Engineering. He is an author over 120 issued U.S. patents and 70 peer-reviewed medical publications. Currently, Dr. Levin is an adjunct associate professor of biomedical engineering at Columbia University, lectures about innovation and entrepreneurship at the Johns Hopkins School of Medicine as well as serves on the External Advisory Board of the Johns Hopkins University Center for Bioengineering Innovation & Design.